Angerbauer R[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
1997	2
1998	2
2022	0

Page 1

Preclinical review of cerivastatin sodium--a step forward in HMG-CoA reductase inhibition.

Bischoff H, Angerbauer R, Boberg M, Petzinna D, Schmidt D, Steinke W, Thomas G. Bischoff H, et al. Among authors: angerbauer r. Atherosclerosis. 1998 Sep;139 Suppl 1:S7-13. doi: 10.1016/s0021-9150(98)00188-9. Atherosclerosis. 1998. PMID: 9811153 Review.

Biotransformation of cerivastatin in mice, rats, and dogs in vivo.

Boberg M, Angerbauer R, Kanhai WK, Karl W, Kern A, Radtke M, Steinke W. Boberg M, et al. Among authors: angerbauer r. Drug Metab Dispos. 1998 Jul;26(7):640-52. Drug Metab Dispos. 1998. PMID: 9660846

Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor.

Bischoff H, Angerbauer R, Bender J, Bischoff E, Faggiotto A, Petzinna D, Pfitzner J, Porter MC, Schmidt D, Thomas G. Bischoff H, et al. Among authors: angerbauer r. Atherosclerosis. 1997 Nov;135(1):119-30. doi: 10.1016/s0021-9150(97)00188-3. Atherosclerosis. 1997. PMID: 9395280

Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved.

Boberg M, Angerbauer R, Fey P, Kanhai WK, Karl W, Kern A, Ploschke J, Radtke M. Boberg M, et al. Among authors: angerbauer r. Drug Metab Dispos. 1997 Mar;25(3):321-31. Drug Metab Dispos. 1997. PMID: 9172950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results